Related Experiment Video
Updated: May 20, 2025
08:43
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
14.7K
Self-Propelled In Situ Polymerized Nanoparticles Activating the STING Pathway for Enhanced Bladder Cancer
Lei Peng1,2, Anguo Zhao2,3, Rongkang Li1,2
1Department of Urology, Lanzhou University Second Hospital, Lanzhou, 730000, P. R. China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|March 26, 2025
Summary
Researchers developed a novel self-propelled nanomedicine system for bladder cancer. This system enhances drug delivery and anti-tumor immunity by activating the STING pathway, improving treatment efficacy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Immunology
Background:
- Bladder cancer poses significant therapeutic challenges due to complex treatment needs.
- Innovative strategies are required to overcome limitations of current bladder cancer therapies.
- Chemotherapy resistance and adverse side effects necessitate novel drug delivery systems.
Purpose of the Study:
- To introduce a novel, self-propelled nanomedicine delivery system for in situ nanoparticle formation within the bladder.
- To enhance nanoparticle retention, drug delivery, and anti-tumor immune responses for bladder cancer treatment.
- To investigate the efficacy of this nanotechnology-based immunomodulatory approach in a preclinical bladder cancer model.
Main Methods:
- Co-infusion of dopamine hydrochloride, Mn2+, cGAMP, and urease to initiate in situ polymerization and form Mn-cGAMP@PDA-urease (DMCU) nanoparticles.
- Utilizing urease-modified nanoparticle surfaces for self-propulsion via urea breakdown, enhancing bladder mucosa retention.
- Activating the STING pathway with nanoparticles to promote dendritic cell maturation and T cell activation for anti-tumor immunity.
Main Results:
- DMCU nanoparticles demonstrated enhanced retention and sustained drug release within the bladder.
- The system effectively activated the STING pathway, leading to increased anti-tumor immune responses.
- In vivo studies in a mouse orthotopic bladder cancer model showed significant tumor suppression and immune activation compared to conventional therapies.
Conclusions:
- The self-propelled nanomedicine system offers a promising strategy for overcoming chemotherapy resistance in bladder cancer.
- This integrated nanotechnology and immunomodulation approach enhances therapeutic efficacy and reduces adverse effects.
- The in situ forming, self-propelled nanoparticles represent a significant advancement in localized bladder cancer treatment.
Related Concept Videos
01:27Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
01:30Cancer Vaccines
310
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
310